车站3
血管生成
生物
癌症研究
细胞生物学
信号转导
作者
Jiazhou Ye,Xing Gao,Xi huang,Shilin Huang,Dandan Zeng,Wenfeng Luo,Can Zeng,Cheng Lǖ,Lu Lu,Hongyang Huang,K. C. Mo,Julu Huang,Shizhou Li,Minchao Tang,Tianzhun Wu,Rongyun Mai,Min Luo,Mingzhi Xie,Shan Wang,Yongqiang Li,Yan Lin,Rong Liang
出处
期刊:Research
[AAAS00]
日期:2024-01-01
卷期号:7
被引量:3
标识
DOI:10.34133/research.0387
摘要
Hepatocellular carcinoma (HCC) was characterized as being hypervascular. In the present study, we generated a single-cell spatial transcriptomic landscape of the vasculogenic etiology of HCC and illustrated overexpressed Golgi phosphoprotein 73 (GP73) HCC cells exerting cellular communication with vascular endothelial cells with high pro-angiogenesis potential via multiple receptor-ligand interactions in the process of tumor vascular development. Specifically, we uncovered an interactive GP73-mediated regulatory network coordinated with c-Myc, lactate, Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) pathway, and endoplasmic reticulum stress (ERS) signals in HCC cells and elucidated its pro-angiogenic roles in vitro and in vivo. Mechanistically, we found that GP73, the pivotal hub gene, was activated by histone lactylation and c-Myc, which stimulated the phosphorylation of downstream STAT3 by directly binding STAT3 and simultaneously enhancing glucose-regulated protein 78 (GRP78)-induced ERS. STAT3 potentiates GP73-mediated pro-angiogenic functions. Clinically, serum GP73 levels were positively correlated with HCC response to anti-angiogenic regimens and were essential for a prognostic nomogram showing good predictive performance for determining 6-month and 1-year survival in patients with HCC treated with anti-angiogenic therapy. Taken together, the aforementioned data characterized the pro-angiogenic roles and mechanisms of a GP73-mediated network and proved that GP73 is a crucial tumor angiogenesis niche gene with favorable anti-angiogenic potential in the treatment of HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI